alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

EXHIBIT 31 (A)

I, John Whetzell certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Northland Cable
     Properties Seven Limited Partnership;

2.   Based on my knowledge, this quarterly report does not contain any untrue
     statement of a material fact or omit to state a material fact necessary to
     make the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     this quarterly report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operations and cash
     flows of the registrant as of, and for, the periods presented in this
     quarterly report;

4.   The registrant's other certifying officer and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we
     have:

          a)   Designed such disclosure controls and procedures, or caused such
               disclosure controls and procedures to be designed under our
               supervision, to ensure that material information relating to the
               registrant, including its consolidated subsidiaries, is made
               known to us by others within those entities, particularly during
               the period in which this quarterly report is being prepared;

          b)   Evaluated the effectiveness of the registrant's disclosure
               controls and procedures and presented in this report our
               conclusions about the effectiveness of the disclosure controls
               and procedures, as of the end of the period covered by this
               report based on such evaluation; and

          c)   Disclosed in this report any change in the registrant's internal
               controls over financial reporting that occurred during the
               registrant's most recent fiscal quarter that has materially
               affected, or is reasonably likely to affect, the registrant's
               internal controls over financial reporting; and

5.   The registrant's other certifying officer and I have disclosed, based on
     our most recent evaluation of internal controls over financial reporting,
     to the registrant's auditors and board of directors:

          a)   All significant deficiencies and material weaknesses in the
               design or operation of internal controls over financial
               reporting, which are reasonably likely to adversely affect the
               registrant's ability to record, process, summarize and report
               financial information; and

          b)   Any fraud, whether or not material, that involves management or
               other employees who have a significant role in the registrant's
               internal controls over financial reporting.

DATE: 11-14-06


/s/ JOHN S. WHETZELL
-------------------------------------
John S. Whetzell
Chief Executive Officer
Exhibit 99.14

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                 SECTIION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Tonga Capital Corp (the "Company") on
Form  10-QSB  for the  period  ending  September  30,  2004 as  filed  with  the
Securities  and  Exchange  Commission  on the date  hereof (the  "Report").  I ,
Jeffrey Ploen, Chief Executive Officer of the Company,  certify,  pursuant to 18
USC 1350, as adopted pursuant to 906 of the  Sarbancs-Oxley Act of 2002, that to
the best of my knowledge and belief.

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934: and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.



                                     /s/ Jeffrey Ploen
                                     Jeffrey Ploen, Chief Executive Officer &
                                                   Chief Financial Officer

Dated: December 1, 2004
Fire Safety for People 

With Disabilities

Millions of Americans live with physical and mental disabilities. It is 

important to know your risk and build your fire prevention plans around 

your abilities.

o Have smoke alarms on every level of your home, inside 

bedrooms and outside sleeping areas. Interconnect 

your alarms, so when one sounds, they all sound.

o If you are deaf or hard of hearing, use smoke alarms 

with a vibrating pad, flashing light or strobe light. These 

accessories start when your alarm sounds.

o Test your alarms every month.

Plan your escape around your abilities.

( Know two ways out of every room.

( If possible, live near an exit.

( You’ll be safest on the ground floor if you live in an apartment building.

( If you live in a multistory home, sleep on the first floor.

( Being on the ground floor and near an exit will make your escape 

easier.

For more information and free resources, visit

www.usfa.fema.gov
IIB 

118TH CONGRESS 

2D SESSION H. R. 7404 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 10, 2024 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To require annual reports on counter illicit cross-border 

tunnel operations, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

HR 7404 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Subterranean Border 

3 Defense Act’’. 

4 SEC. 2. ANNUAL REPORTS ON COUNTER ILLICIT CROSS5 BORDER TUNNEL OPERATIONS. 

6 Paragraph (2) of section 7134(a) of the James M. 

7 Inhofe National Defense Authorization Act for Fiscal Year 

8 2023 (Public Law 117–263; 6 U.S.C. 257 note) is amend9 ed by inserting ‘‘and annually thereafter’’ after ‘‘develop10 ment of the strategic plan’’. 

Passed the House of Representatives September 9, 

2024. 

Attest: KEVIN F. MCCUMBER, 

Clerk. 


ssavage on LAPJG3WLY3PROD with BILLS
Exhibit 14.2





[BDO Limited Letterhead]





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-102288 and 333-92491) pertaining to the Employee Stock Option plans of Ellomay Capital Ltd. (“the Company”) and Form F-3 (File Nos. 333-144171, 333-115826, 333-114428, 333-47842 and 333-92493) of the Company and in the related Prospectus of our report dated June 26, 2008 with respect to the financial statements of NUR Asia Pacific Limited included in the Annual Report on Form 20-F of Ellomay Capital Ltd. for the year ended December 31, 2009.




We take this opportunity to inform you that BDO McCabe Lo Limited changed its name to BDO Limited on May 1, 2009.


/s/ BDO Limited


__________________________


BDO Limited


Certified Public Accountants





March 10, 2010
<PAGE>   1
                                                                    EXHIBIT 3.14
                            CERTIFICATE OF AMENDMENT

                     TO THE CERTIFICATE OF INCORPORATION OF

                         GLOBAL TELESYSTEMS GROUP, INC.


         GLOBAL TELESYSTEMS GROUP, INC., a Delaware corporation, HEREBY
CERTIFIES AS FOLLOWS:

         1. The name of the Corporation is Global TeleSystems Group, Inc. The
date of filing of its Certificate of Incorporation with the Secretary of State
of the State of Delaware was September 30, 1993.

         2. This Certificate of Amendment sets forth amendments to the
Certificate of Incorporation of the Corporation that were duly adopted by the
vote of the holders of a majority of the outstanding stock of the Corporation
entitled to vote thereon in accordance with the provisions of Section 242 of the
General Corporation Law of the State of Delaware.

         3. The first paragraph of Article FOURTH of the Certificate of
Incorporation of the Corporation is hereby amended to read as follows:

                  "FOURTH: The total number of shares of capital stock which the
         Corporation shall have authority to issue is 280,000,000 (two hundred
         eighty million) shares, of which there shall be 270,000,000 (two
         hundred seventy million) shares of common stock, par value $0.10 per
         share, and 10,000,000 (ten million) shares of preferred stock, par
         value $0.0001 per share."

         IN WITNESS WHEREOF, GLOBAL TELESYSTEMS GROUP, INC. has caused this
certificate to be signed by Vimal Agarwal, its Vice President and Treasurer, and
attested by Arnold Y. Dean, its Assistant Secretary, this 18th day of June,
1999.

                                         GLOBAL TELESYSTEMS GROUP, INC.


                                         By: /s/ Vimal Agarwal
                                            ------------------------------------
                                         Name: Vimal Agarwal
                                         Title: Vice President and Treasurer

ATTEST:


By: /s/ Arnold Y. Dean
--------------------------
Name: Arnold Y. Dean
Title: Assistant Secretary
<PAGE>

                                                                    EXHIBIT 23.2



                         INDEPENDENT AUDITORS' REPORT

To the Board of Directors and Stockholders of
Eagle Point Software Corporation
Dubuque, Iowa

We have audited the consolidated financial statements of Eagle Point Software
Corporation and Subsidiary (Company) as of June 30, 1999 and 1998, and for each
of the three years in the period ended June 30, 1999, and have issued our report
thereon dated July 30, 1999. Our audits also include the financial statement
schedule of the Company listed in Item 14. This financial statement schedule is
the responsibility of the Company's management. Our responsibility is to express
an opinion based on our audits. In our opinion, such financial statement
schedule, when considered in relation to the basic financial statements taken as
a whole, presents fairly in all material respects the information set forth
therein.



Des Moines, Iowa
September 17, 1999
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hutton Investors Futures Fund L.P. II (the ‘‘Partnership’’) on Form 10-Q for the period ending March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the ‘‘Report’’), I, Jennifer Magro, Chief Financial Officer and Director of Citigroup Managed Futures LLC, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.

/s/ Jennifer Magro

|  |
|--|
|  |  |
|  |

Jennifer MagroCitigroup Managed Futures LLC Chief Financial Officer and Director

Date: May 14, 2007

----
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-START>                                 Jan-01-2000
<PERIOD-END>                                   Sep-30-2000
<CASH>                                               3,822
<SECURITIES>                                             0
<RECEIVABLES>                                            0
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                     4,855
<PP&E>                                             918,000
<DEPRECIATION>                                     368,887
<TOTAL-ASSETS>                                   1,244,700
<CURRENT-LIABILITIES>                              539,941
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                            22,384
<OTHER-SE>                                         257,247
<TOTAL-LIABILITY-AND-EQUITY>                     1,244,700
<SALES>                                             26,400
<TOTAL-REVENUES>                                    26,400
<CGS>                                                    0
<TOTAL-COSTS>                                      172,334
<OTHER-EXPENSES>                                  (175,000)
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                  45,175
<INCOME-PRETAX>                                          0
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                               (489,383)
<DISCONTINUED>                                    (756,515)
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                    (1,245,898)
<EPS-BASIC>                                           (.01)
<EPS-DILUTED>                                         (.01)



</TABLE>
Exhibit 4.3


 


Consent of Independent Registered
Public Accounting Firm


We consent to the
reference made to our firm under the caption “Independent Registered Public Accounting Firm” in Part B of the Prospectus
and to the use of our report dated April 26, 2017, in this Registration Statement (Form S-6 No. 333-215958) of Smart Trust 315,
comprising Smart Trust, Miller/Howard North American Energy Opportunities Trust, Series 6.


 


/s/ Grant
Thornton LLP


 


Chicago, Illinois


April 26, 2017
§ 520.1468 Naproxen. ( a ) *Specifications.* Each gram of granules contains 500 milligrams (mg) (50 percent) naproxen.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses* — ( 1 ) *Amount.* 10 mg per kilogram of body weight twice daily top dressed on feed for up to 14 consecutive days.
( 2 ) *Indications for use.* For the relief of inflammation and associated pain and lameness exhibited with arthritis, as well as myositis and other soft tissue diseases of the musculoskeletal system.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[78 FR 28825, May 20, 2014]
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1317 Garlic and its derivatives. ( a ) Garlic is the fresh or dehydrated bulb or cloves obtained from *Allium sativum,* a genus of the lily family. Its derivatives include essential oils, oleo-resins, and natural extractives obtained from garlic.
( b ) Garlic oil meets the specifications of the “Food Chemicals Codex,” 3d Ed. (1981), p. 132, which is incorporated by reference. Copies may be obtained from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or may be examined at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) Garlic and its derivatives are used as flavoring agents and adjuvants as defined in § 170.3(o)(12) of this chapter.
( d ) The ingredients are used in food at levels not to exceed good manufacturing practice.
( e ) [Reserved]
( f ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[42 FR 14653, Mar. 15, 1977, as amended at 42 FR 55205, Oct. 14, 1977; 49 FR 5612, Feb. 14, 1984]
[No. 38732-4-I.

Division One.

October 27, 1997.]

#### The State of Washington, *Respondent,*v. James Warren Crow, *Appellant.*

Appeal from a judgment of the Superior Court for Snohomish County, No. 96-1-00356-0, Gerald L. Knight, J., entered May 10,1996. *Affirmed*by unpublished per curiam opinion.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<LEGEND>
                              THIS SCHEDULE CONTAINS SUMMARY FINANCIAL 
                              INFORMATION EXTRACTED FROM THE COMPANY'S FINANCIAL
                              STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
                              REFERENCE TO SUCH FINANCIAL STATEMENTS INCLUDED
                              AS A PART OF THIS FORM 20-F
</LEGEND>
[ARTICLE]                     5
<MULTIPLIER>                                     1,000
<CURRENCY>                                           $
       
<S>                             <C>
<PERIOD-TYPE>                                     Year
<FISCAL-YEAR-END>                          Dec-31-1996
<PERIOD-START>                             Jan-01-1996
<PERIOD-END>                               Dec-31-1996
<EXCHANGE-RATE>                                      1
<CASH>                                           1,738
<SECURITIES>                                         0
<RECEIVABLES>                                    6,568
<ALLOWANCES>                                       606
<INVENTORY>                                      2,569
<CURRENT-ASSETS>                                10,269
<PP&E>                                           1,024
<DEPRECIATION>                                     343
<TOTAL-ASSETS>                                  12,161
<CURRENT-LIABILITIES>                            9,579
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,593
<OTHER-SE>                                         243
<TOTAL-LIABILITY-AND-EQUITY>                    12,161
<SALES>                                         16,637
<TOTAL-REVENUES>                                16,637
<CGS>                                           13,536
<TOTAL-COSTS>                                   11,692
<OTHER-EXPENSES>                                   (98)
<LOSS-PROVISION>                                   606
<INTEREST-EXPENSE>                                 589
<INCOME-PRETAX>                                 (9,688)
<INCOME-TAX>                                       400
<INCOME-CONTINUING>                            (10,088)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (10,088)
<EPS-PRIMARY>                                    (1.47)
<EPS-DILUTED>                                    (1.47)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                      31,683,869
<SECURITIES>                                53,558,075
<RECEIVABLES>                                5,280,855
<ALLOWANCES>                                   229,549
<INVENTORY>                                          0
<CURRENT-ASSETS>                            74,719,663
<PP&E>                                      10,381,446
<DEPRECIATION>                               5,014,628
<TOTAL-ASSETS>                             137,654,555
<CURRENT-LIABILITIES>                       10,210,796
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       203,008
<OTHER-SE>                                 118,759,511
<TOTAL-LIABILITY-AND-EQUITY>               137,654,555
<SALES>                                     30,550,746
<TOTAL-REVENUES>                            30,550,746
<CGS>                                       17,231,152
<TOTAL-COSTS>                               70,388,827
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             117,615
<INCOME-PRETAX>                            (35,508,793)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (35,508,793)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (35,508,793)
<EPS-PRIMARY>                                    (1.94)
<EPS-DILUTED>                                    (1.94)
        

</TABLE>
§ 520.905c Fenbendazole paste. ( a ) *Specifications.* Each gram of paste contains 100 milligrams (mg) fenbendazole (10 percent).
( b ) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.275 of this chapter.
( d ) *Special considerations.* See § 500.25 of this chapter.
( e ) *Conditions of use* — ( 1 ) *Horses* — ( i ) *Indications for use and amounts.* ( A ) For the treatment and control of large strongyles (*Strongylus edentatus, S. equinus,* *S. vulgaris*), small strongyles, and pinworms (*Oxyuris equi*). For large strongyles, small strongyles, and pinworms, the recommended dose is 5 mg/kg (2.3 mg/lb).
( B ) For treatment and control of ascarids (*Parascaris equorum*). For ascarids, the recommended dose is 10 mg/kg (4.6 mg/lb).
( C ) For treatment and control of hypobiotic (encysted early third-stage), late third-stage, and fourth-stage cyathostome larvae, as well as fourth-stage *Strongylus vulgaris* larvae, the recommended dose is 10 mg/kg (4.6 mg/lb) daily for 5 consecutive days.
( D ) For the control of arteritis caused by fourth-stage larvae of *Strongylus vulgaris* in horses.
( E ) Fenbendazole paste 10 percent may be used concomitantly with approved forms of trichlorfon for the indications provided in paragraph (e)(1)(i)(A) of this section and for treating infections of stomach bots as provided in § 520.2520.
( ii ) *Limitations.* Do not use in horses intended for human consumption.
( 2 ) *Beef and dairy cattle* — ( i ) *Amount.* Administer orally 2.3 mg/lb (5 mg/kg) body weight.
( ii ) *Indications for use.* For the treatment and control of: Lungworms: Adult (*Dictyocaulus viviparus*); Stomach worms: Adult brown stomach worms (*Ostertagia ostertagi*), adult and fourth-stage larvae barberpole worms (*Haemonchus contortus*), fourth-stage larvae barberpole worms (*H. placei*), and adult and fourth-stage larvae small stomach worms (*Trichostrongylus axei*); Intestinal worms (adult and fourth-stage larvae): Hookworms (*Bunostomum phlebotomum*), thread-necked intestinal worms (*Nematodirus helvetianus*), small intestinal worms (*Cooperia punctata* and *C. oncophora*), bankrupt worms (*Trichostrongylus colubriformis*), and nodular worms (*Oesophagostomum radiatum*).
( iii ) *Limitations.* Milk taken during treatment and for 96 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 8 days following last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in preruminating calves.
[72 FR 24185, May 2, 2007, as amended at 74 FR 61516, Nov. 25, 2009; 76 FR 17337, Mar. 29, 2011; 86 FR 57996, Oct. 20, 2021; 87 FR 10968, Feb. 28, 2022]